The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitorsMario Mandalà, Roberta De Penni, Michele Guida et al.|Journal for ImmunoTherapy of Cancer|2019Cited by 68
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediatorsElisabetta Vergani, Viviana Vallacchi, Matteo Dugo et al.|Cell Communication and Signaling|2020Cited by 36
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional ProfilesElisabetta Vergani, Monica Rodolfo, Adele Busico et al.|Journal of Investigative Dermatology|2022Cited by 14
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with <i>BRAF</i> Mutated MelanomaLorenza Di Guardo, Michele Del Vecchio, Giovanni Randon et al.|The Oncologist|2021Cited by 10
Survival in Patients With Sentinel Node–Positive Melanoma With Extranodal ExtensionAndrea Maurichi, Mario Santinami, Francesco Barretta et al.|Journal of the National Comprehensive Cancer Network|2021Cited by 7